ArticleBrain and behavior2025
Non-Cyclical Mastalgia as a Central Sensitization Component: Implications for Multidisciplinary Treatment Approaches.
Article in Brain and behavior, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Non-Cyclical Mastalgia as a Central Sensitization Component: Implications for Multidisciplinary Treatment Approaches.Brain and behavior · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivesNon-Cyclical mastalgia (NCM) is a chronic breast pain condition in women of reproductive age, often linked to anxiety and reduced quality of life (QoL). Evidence suggests central sensitization (CS) may contribute to NCM, but its clinical significance and management remain unclear.
methodsThis cross-sectional study included 201 women aged 25 to 65, with 106 NCM patients and 95 healthy controls, to investigate the association between NCM and central sensitization syndromes (CSS). Data collection involved demographic characteristics and assessments using the Central Sensitization Inventory (CSI), Nottingham Health Profile (NHP), Short-Form McGill Pain Questionnaire (SF-MPQ), Pain Detect, Leeds Assessment of Neuropathic Symptoms and Signs (LANSS), and Hospital Anxiety and Depression Scale (HADS). The main outcome is to reveal the interrelationship between NCM and CSS.
resultsNCM patients had significantly higher Central Sensitization Inventory-A (CSI-A) scores than controls (p < 0.001), with 15.1% surpassing the critical threshold of 40, indicating pronounced CS. NCM patients also had increased NHP-1, NHP-2, and HADS-total scores (p = 0.008, p = 0.003, p = 0.004), reflecting greater distress. Subgroup analyses showed more intense pain (p < 0.001) and sleep disturbances (p = 0.002). CSI-A scores strongly correlated with SF-MPQ, LANSS, Pain Detect, and HADS (all p < 0.001). Regression analysis identified pain duration, Pain Detect, and SF-MPQ sensory scores as key predictors of CSI-A (p < 0.001). DISCUSSION: NCM shares characteristics with chronic pain syndromes linked to CSS. Multidisciplinary approaches and innovative treatments, such as cognitive therapies combined with integrative approaches may improve outcomes.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.